Tangdu Hospital, the Fourth Military Medical University
Welcome,         Profile    Billing    Logout  
 4 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
He, XianLi
KEYNOTE-585 China Extension study, NCT04882241: Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

Active, not recruiting
3
120
RoW
Pembrolizumab, MK-3475, KEYTRUDA®, Placebo, Normal saline solution, Cisplatin, PLATINOL®, Capecitabine, XELODA®, 5-fluorouracil, ADRUCIL®, 5FU, Docetaxel, TAXOTERE®, Oxaliplatin, ELOXATIN®, Leucovorin, WELLCOVORIN®
Merck Sharp & Dohme LLC
Gastric Cancer, Gastroesophageal Junction Cancer
02/24
04/25
Deng, Jianping
NCT05544045: China Surpass Streamline Post-Market Study

Terminated
N/A
11
RoW
Surpass Streamline Flow Diverter System
Stryker Neurovascular, Stryker (Beijing) Healthcare Products Co., Ltd
Aneurysm, Intracranial
09/23
09/23
Lian, Jianqi
ALTN-AK105-III-02, NCT04344158: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Active, not recruiting
3
648
RoW
AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Hepatocellular Carcinoma (HCC)
12/26
12/26
Zhao, Zhenwei
NCT05898893: PARAT PLUS (The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms)

Recruiting
N/A
99
RoW
Microport NeuroTech Tubridge Plus flow-diverter Stent
MicroPort NeuroTech Co., Ltd.
Intracranial Aneurysm
03/24
12/24
Chang, Ting
NIMBLE, NCT05070858 / 2020-003272-41: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Recruiting
3
235
Europe, Canada, Japan, US, RoW
Pozelimab + Cemdisiran, Cemdisiran, ALN-CC5, Placebo, Pozelimab, REGN3918
Regeneron Pharmaceuticals
Generalized Myasthenia Gravis
05/25
03/28
SPH-B007-303, NCT06447597: A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

Recruiting
2/3
104
RoW
B007, Placebo
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Generalized Myasthenia Gravis
06/26
06/26
NCT05343481: Efficacy of VTP-300 in Chronic Hepatitis B Infection

Active, not recruiting
2
120
RoW
ChAdOx1-HBV, MVA-HBV, Nivolumab, Opdivo 10mg/ml concentrate for solution for infusion
Barinthus Biotherapeutics
Chronic Hepatitis B
02/25
10/26

Download Options